Jessica Bindra1, Paul Pham1, Anders Aneman1,2, Alwin Chuan1,3, Matthias Jaeger4,5. 1. University of New South Wales, South Western Sydney Clinical School, Locked Bag 7103, Liverpool BC, NSW, 1871, Australia. 2. Department of Intensive Care Medicine, Liverpool Hospital, Liverpool, NSW, Australia. 3. Department of Anaesthesia, Liverpool Hospital, Liverpool, NSW, Australia. 4. University of New South Wales, South Western Sydney Clinical School, Locked Bag 7103, Liverpool BC, NSW, 1871, Australia. m.jaeger@unsw.edu.au. 5. Department of Neurosurgery, Wollongong Hospital, Wollongong, NSW, Australia. m.jaeger@unsw.edu.au.
Abstract
BACKGROUND: Near infrared spectroscopy (NIRS) enables continuous monitoring of dynamic cerebrovascular autoregulation, but this methodology relies on invasive blood pressure monitoring (iABP). We evaluated the agreement between a NIRS based autoregulation index calculated from invasive blood pressure monitoring, and an entirely non-invasively derived autoregulation index from continuous non-invasive blood pressure monitoring (nABP) using the Finometer photoplethysmograph. METHODS: Autoregulation was calculated as the moving correlation coefficient between iABP and rSO2 (iTOx) or nABP and rSO2 (nTOx). The blood pressure range where autoregulation is optimal was also determined for invasive (iABPOPT) and non-invasive blood pressure measurements (nABPOPT). RESULTS: 102 simultaneous bilateral measurements of iTOx and nTOx were performed in 19 patients (median 2 per patient, range 1-9) with different acute pathologies (sepsis, cardiac arrest, head injury, stroke). Average iTOx was 0.01 ± 0.13 and nTOx was 0.01 ± 0.11. The correlation between iTOx and nTOx was r = 0.87, p < 0.001, 95 % agreement ± 0.12, bias = 0.005. The interhemispheric asymmetry of autoregulation was similarly assessed with iTOx and nTOx (r = 0.81, p < 0.001). Correlation between iABPOPT and nABPOPT was r = 0.47, p = 0.003, 95 % agreement ± 32.1 mmHg, bias = 5.8 mmHg. Coherence in the low frequency spectrum between iABP and nABP was 0.86 ± 0.08 and gain was 1.32 ± 0.77. CONCLUSIONS: The results suggest that dynamic cerebrovascular autoregulation can be continuously assessed entirely non-invasively using nTOx. This allows for autoregulation assessment using spontaneous blood pressure fluctuations in conditions where iABP is not routinely monitored. The nABPOPT might deviate from iABPOPT, likely because of discordance between absolute nABP and iABP readings.
BACKGROUND: Near infrared spectroscopy (NIRS) enables continuous monitoring of dynamic cerebrovascular autoregulation, but this methodology relies on invasive blood pressure monitoring (iABP). We evaluated the agreement between a NIRS based autoregulation index calculated from invasive blood pressure monitoring, and an entirely non-invasively derived autoregulation index from continuous non-invasive blood pressure monitoring (nABP) using the Finometer photoplethysmograph. METHODS: Autoregulation was calculated as the moving correlation coefficient between iABP and rSO2 (iTOx) or nABP and rSO2 (nTOx). The blood pressure range where autoregulation is optimal was also determined for invasive (iABPOPT) and non-invasive blood pressure measurements (nABPOPT). RESULTS: 102 simultaneous bilateral measurements of iTOx and nTOx were performed in 19 patients (median 2 per patient, range 1-9) with different acute pathologies (sepsis, cardiac arrest, head injury, stroke). Average iTOx was 0.01 ± 0.13 and nTOx was 0.01 ± 0.11. The correlation between iTOx and nTOx was r = 0.87, p < 0.001, 95 % agreement ± 0.12, bias = 0.005. The interhemispheric asymmetry of autoregulation was similarly assessed with iTOx and nTOx (r = 0.81, p < 0.001). Correlation between iABPOPT and nABPOPT was r = 0.47, p = 0.003, 95 % agreement ± 32.1 mmHg, bias = 5.8 mmHg. Coherence in the low frequency spectrum between iABP and nABP was 0.86 ± 0.08 and gain was 1.32 ± 0.77. CONCLUSIONS: The results suggest that dynamic cerebrovascular autoregulation can be continuously assessed entirely non-invasively using nTOx. This allows for autoregulation assessment using spontaneous blood pressure fluctuations in conditions where iABP is not routinely monitored. The nABPOPT might deviate from iABPOPT, likely because of discordance between absolute nABP and iABP readings.
Authors: Kenneth Brady; Brijen Joshi; Christian Zweifel; Peter Smielewski; Marek Czosnyka; R Blaine Easley; Charles W Hogue Journal: Stroke Date: 2010-07-22 Impact factor: 7.914
Authors: Jennifer Diedler; Marek Sykora; André Rupp; Sven Poli; Georg Karpel-Massler; Oliver Sakowitz; Thorsten Steiner Journal: Stroke Date: 2009-01-08 Impact factor: 7.914
Authors: Marcel J H Aries; Marek Czosnyka; Karol P Budohoski; Luzius A Steiner; Andrea Lavinio; Angelos G Kolias; Peter J Hutchinson; Ken M Brady; David K Menon; John D Pickard; Peter Smielewski Journal: Crit Care Med Date: 2012-08 Impact factor: 7.598
Authors: Jennifer Diedler; Christian Zweifel; Karol P Budohoski; Magdalena Kasprowicz; Enrico Sorrentino; Christina Haubrich; Kenneth M Brady; Marek Czosnyka; John D Pickard; Peter Smielewski Journal: Anesth Analg Date: 2011-08-04 Impact factor: 5.108
Authors: Luzius A Steiner; David Pfister; Stephan P Strebel; Danila Radolovich; Peter Smielewski; Marek Czosnyka Journal: Neurocrit Care Date: 2008-09-20 Impact factor: 3.210
Authors: Luzius A Steiner; Marek Czosnyka; Stefan K Piechnik; Piotr Smielewski; Doris Chatfield; David K Menon; John D Pickard Journal: Crit Care Med Date: 2002-04 Impact factor: 7.598
Authors: David Pfister; Martin Siegemund; Salome Dell-Kuster; Peter Smielewski; Stephan Rüegg; Stephan P Strebel; Stephan C U Marsch; Hans Pargger; Luzius A Steiner Journal: Crit Care Date: 2008-05-05 Impact factor: 9.097
Authors: Paul Pham; Jessica Bindra; Anders Aneman; Alwin Chuan; John M Worthington; Matthias Jaeger Journal: Neurocrit Care Date: 2019-02 Impact factor: 3.210